Literature DB >> 18266710

Exacerbations worsen the quality of life of chronic obstructive pulmonary disease patients in primary healthcare.

C Llor1, J Molina, K Naberan, J M Cots, F Ros, M Miravitlles.   

Abstract

AIMS: To investigate the evolution of the quality of life of patients with chronic obstructive pulmonary disease (COPD) and quantify the impact of exacerbations on the deterioration of quality of life over 2 years.
METHODS: Multicentre, observational, prospective 2-year study carried out in primary care. Patients with COPD were seen every 6 months. All the exacerbations developing during the study period were recorded and the quality of life of these patients was measured with the St. George's Respiratory Questionnaire (SGRQ).
RESULTS: Twenty-seven physicians participated and collected information on 136 patients with a mean age of 70 years (SD: 9.7) and a mean forced expiratory volume in 1 s (FEV(1)) of 48.7% predicted (SD: 14.5%). The mean global score of the SGRQ was 39.6 at the beginning of the study and 37.9 at the end. Patients without exacerbations improved an average of -5.32 units compared with a worsening of +0.2 among patients with exacerbations (p = 0.023). Among the latter, patients with only one exacerbation improved -3.8 units (p = 0.012) compared with a worsening of +2.4 in those with two or more exacerbations (p = 0.134). The impact of exacerbations was greater in patients with more preserved pulmonary function, with a change in the SGRQ among patients with or without exacerbations of +0.23 and -6.17 (p = 0.017), respectively in patients with a FEV(1) > 50%, vs. +0.18 and -4.39 (p = 0.32) in patients with a FEV(1) </= 50%.
CONCLUSIONS: Exacerbations are associated with a significant worsening in the quality of life of patients with COPD measured with the SGRQ. The degree of impairment depends on the number of exacerbations, being greater in patients with more preserved pulmonary function.

Entities:  

Mesh:

Year:  2008        PMID: 18266710     DOI: 10.1111/j.1742-1241.2008.01707.x

Source DB:  PubMed          Journal:  Int J Clin Pract        ISSN: 1368-5031            Impact factor:   2.503


  17 in total

Review 1.  Systematic review of humanistic and economic burden of symptomatic chronic obstructive pulmonary disease.

Authors:  Kunal Srivastava; Deepika Thakur; Sheetal Sharma; Yogesh Suresh Punekar
Journal:  Pharmacoeconomics       Date:  2015-05       Impact factor: 4.981

2.  Antibiotic treatment of exacerbations of COPD in general practice: long-term impact on health-related quality of life.

Authors:  Marc Miravitlles; Carles Llor; Jesús Molina; Karlos Naberan; Josep M Cots; Fernando Ros
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-02-18

3.  Depression Is Associated with Readmission for Acute Exacerbation of Chronic Obstructive Pulmonary Disease.

Authors:  Anand S Iyer; Surya P Bhatt; Jeffrey J Garner; J Michael Wells; Jennifer L Trevor; Neha M Patel; deNay Kirkpatrick; John C Williams; Mark T Dransfield
Journal:  Ann Am Thorac Soc       Date:  2016-02

4.  Exacerbation frequency and course of COPD.

Authors:  David M G Halpin; Marc Decramer; Bartolome Celli; Steven Kesten; Dacheng Liu; Donald P Tashkin
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-21

5.  Direct costs of chronic obstructive pulmonary disease among managed care patients.

Authors:  Anand A Dalal; Laura Christensen; Fang Liu; Aylin A Riedel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-10-05

Review 6.  Association between lung function and exacerbation frequency in patients with COPD.

Authors:  Martine Hoogendoorn; Talitha L Feenstra; Rudolf T Hoogenveen; Maiwenn Al; Maureen Rutten-van Mölken
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2010-12-09

7.  A novel study design for antibiotic trials in acute exacerbations of COPD: MAESTRAL methodology.

Authors:  Robert Wilson; Antonio Anzueto; Marc Miravitlles; Pierre Arvis; Geneviève Faragó; Daniel Haverstock; Mila Trajanovic; Sanjay Sethi
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-06-29

8.  Cost trends among commercially insured and Medicare Advantage-insured patients with chronic obstructive pulmonary disease: 2006 through 2009.

Authors:  Anand A Dalal; Fang Liu; Aylin A Riedel
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2011-10-14

9.  Incidence and risk factors of exacerbations among COPD patients in primary health care: APMPOC study.

Authors:  Eulàlia Borrell; Mar Rodríguez; Pere Torán; Laura Muñoz; Guillem Pera; Núria Montellà; Mònica Monteagudo; Magalí Urrea; Yolanda Puigfel; Antonio Negrete; Xavier Mezquiriz; Cristina Domènech; Anna Lacasta; Ma Llum García; Sandra Maneus; Glòria Tintoré
Journal:  BMC Public Health       Date:  2009-01-09       Impact factor: 3.295

10.  Efficacy of amoxycillin versus amoxycillin/clavulanate in acute exacerbations of chronic pulmonary obstructive disease in primary care.

Authors:  Carl Llor; Silvia Hernández; Anna Ribas; Carmen Alvarez; Josep Maria Cots; Carolina Bayona; Isabel González; Marc Miravitlles
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2009-04-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.